CC 1 AND 2 Flashcards
traditional markers (7)
fbs rbs ogtt hba1c aer acr gfr
disadvantages of traditional DM markers
inconvenient
invasive
time consuming
hgb variants
novel DM markers (miRNA)
7
192, 193b, 103
9, 29a
126, 15a
novel DM markers (proteins)
2
adiponectin
RBP 4
novel DM markers (metabolites)
2
glycine
hydroxybutyrate
novel DN inflammatory markers
3
TNF-a
TNF-a receptors
interferon gamma
novel DN oxidative stress markers
2
8-OHdG
MDA
novel DN renal dysfunction marker
1
KIM-1
miRNA elevated during prediabetes
192, 193b
miRNA involved in regulation of adipose and glucose metabolism; decreased in prediabetes
103
this miRNA can inhibit insulin secretion; elevated in T2DM
9, 29a
miRNA involved in endothelial homeostasis, decreased in both prediabetes and T2DM
126
this miRNA promotes insulin regulation; decreased in T2DM
15a
potential predictive miRNA markers for DM (2)
126, 15a
protein that promotes glucose uptake; decreased in T2DM
adiponectin
transporter protein for retinol; increased in T2DM
RBP4
substrate for gluconeogenesis; decreased in insulin resistance
glycine
amino acid metabolite; increased in insulin resistance
hydroxybutyrate
promotes chemokine release
TNF-a
predictors for ESRD (2)
TNFR1
TNFR2
have normal physiologic function but they may also be dangerous if they are present in excessively high levels
reactive oxygen species
nucleic acid oxidation product; predictor of DN progression
8-OHdG
lipid oxidation product; increased in CKD, T2DM, DN
MDA
transmembrane protein on PCT cells; increased in tubular injury
KIM-1
berlin criteria for ARDS (3)
- onset of symptoms < 1 week
- bilateral opacities w/ pulmonary edema
- PF/Horowitz ratio < 300 mmHg
alveolar cells type 1 secretes:
sRAGE
alveolar cells type 2 secretes: (3)
SP-A
SP-B
SP-D
bronchiolar club cells secretes:
CCSP
endothelial cells secretes: (5)
exudative phase
- vWF
- sICAM-1
- Ang-1
- Ang-2
- E-selectin
pulmonary vascular permeability secretes:
- mini-BALF
- plasma proteins
coagulation secretes:
- PAI
- protein C
- thrombomodulin
- urokinase
ARDS biomarker that peaks at first day; increased in severe lung dysfunction
sRAGE
this protein + IL-8 is considered as a superior performing biomarker in ARDS diagnosis
SP - surfactant protein
increased volume of this ARDS biomarker is linked to worsening of clinical outcome
CCSP
increased levels of this ARDS biomarker on the 1st 3 days suggests poor clinical outcome
sICAM-1
this ARDS biomarker is decreased in ARDS
Ang-1
phase of ARDS - first 7 days
exudative phase
exudative phase biomarkers
- sRAGE
- SP
- CCSP
- sICAM
- Ang-1/2
- E-selectin
phase of ARDS - 7th day to recovery
proliferative phase
epithelial cells secretes:
KGF and HGF
potent mitogens, has poor prognosis
KGF and HGF
endothelial cells secretes: (proliferative phase)
VEGF
ARDS vs COVID
ARDS
- multiple cells
- onset < a week
- non compliant respiratory system
COVID-ARDS
- alveolar cells only
- 8-14 days onset
- compliant respiratory system
Best marker in predicting disease severity as it is decreased for fatal patients
total thiol
high sensitivity biomarker; capable of distinguishing non-ARDS from severe ARDS patients
ferritin